Solidsoft Reply Limited is a UK-based consulting and technology company active since 1993, specializing in cloud-based solutions primarily for the healthcare and pharmaceutical sectors. With over 30 years of experience and a team of 51-200 employees, Solidsoft Reply drives innovation in digital applications, clinical integrations, and pharmaceutical safety systems. The company’s expertise lies in developing cloud-based verification and track-and-trace systems to enhance medicine safety, governance, and operational efficiency in the pharmaceutical industry.
The firm is recognized for its collaboration with global organizations such as UNICEF and its involvement in safeguarding pharmaceutical supply chains. Notably, Solidsoft Reply supports the European Medicines Verification System (EMVS) and oversees 14 National Medicines Verification Systems across Europe, helping to protect citizens from counterfeit medicines. Its VeriLite scanning solution empowers wholesalers and pharmacists to verify medicines at points of dispensing, ensuring end-to-end traceability and accountability.
Solidsoft Reply leverages advanced technologies, including Microsoft AI Cloud solutions built on Microsoft Azure infrastructure, to transform healthcare experiences and support business growth. This commitment to innovation and industry excellence positions Solidsoft Reply as a leading thought leader and trusted partner within healthcare, pharmaceutical, not-for-profit, and social impact sectors.
The evolving pharmaceutical market, with its new business models, disruptive technologies, and shifts toward patient empowerment and preventative care, creates a dynamic context in which Solidsoft Reply operates. The firm continues to adapt to increased pressures faced by the pharma industry, amplified during the COVID-19 pandemic, promoting rapid product development, collaboration, and remote accessibility to critical systems and data.
Solidsoft Reply’s strong technological foundation and strategic partnerships enable it to meet emerging challenges and opportunities in pharmaceutical operations, delivering transformative impact through its digital platforms.
